Skip to main content
Pharma and Healthcare

Case Study: Does Branding Impact Sales?

How OSG helped a global pharmaceutical company evaluate and prioritize potential scientific statements intended to launch an unbranded campaign to educate physicians before the launch of Drug X.

A global pharmaceutical company and its agency of record were planning to launch an unbranded campaign to shape the opioid-induced nausea and vomiting (OINV) treatment market for the later launch of Drug X and thus wanted to test potential scientific statements that would boost this campaign. Using OSG’s AI-driven big data analytics platform, we conducted research in the United States to prioritize messages designed to launch a campaign that educates physicians about OINV and drives them to seek more information.

Check out more of our case studies:

Case Study: Differentiation for Biosimilars

How OSG’s technology helped a pharma company stand out in their first foray into an already crowded category of biosimilar products, through stakeholder understanding and position and reputation management.

Case Study: Empowering Electrical Contractors

How OSG helped a global specialist in energy management and automation build a measurement infrastructure to better engage with customers to impact acquisition and purchases.